HCA insider filings

HCA Healthcare, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen HCA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 9 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Foster Jon M — EVP and COO1—8 legs · 31,713 sh · $15,887,4824
Rossitto Erica — SVP & Chief Nurse Executive1—1 leg · 3,500 sh · $1,770,3355
Schlosser Michael J — EVP and Chief Clinical Officer3—1 leg · 1,200 sh · $593,5838
Marks Mike A — EVP and CFO1——5
Elcan Patricia F — 10% owner1——2
FRIST THOMAS F III — Director, 10% owner1——2
McAlevey Michael R — EVP & Chief Legal & Admin Off.1——1

Recent insider filings — HCA Healthcare, Inc.

FiledFormInsiderReported transactionsSource
2026-11-174Schlosser Michael J — EVP and Chief Clinical OfficerGift (G): 1,273 @ $0 · Gift (G): 1,273 @ $0EDGAR
2026-11-104Rossitto Erica — SVP & Chief Nurse ExecutiveOption exercise (M): 8,080 @ $81.96 · Option exercise (M): 5,040 @ $101.16 · Tax withholding (F): 6,601 @ $494.99 · Sale (S): 3,500 @ $505.81 · Option exercise (M): 8,080 (derivative) @ $0 · Option exercise (M): 5,040 (derivative) @ $0EDGAR
2026-11-064Elcan Patricia F — 10% ownerOther (J): 886,871 @ $503.52 · Other (J): 886,871 @ $503.52EDGAR
2026-11-064FRIST THOMAS F III — Director, 10% ownerOther (J): 555,500 @ $503.52 · Other (J): 555,500 @ $503.52EDGAR
2026-11-064Schlosser Michael J — EVP and Chief Clinical OfficerSale (S): 1,200 @ $494.65EDGAR
2026-11-064Foster Jon M — EVP and COOSale (S): 10,000 @ $514.07 · Option exercise (M): 35,880 @ $145.24 · Tax withholding (F): 20,309 @ $510.70 · Other (J): 16,142 @ $503.52 · Sale (S): 890 @ $498.97 · Sale (S): 1,684 @ $498.00 · +6 moreEDGAR
2026-11-034Marks Mike A — EVP and CFOOption exercise (M): 4,585 @ $81.96 · Tax withholding (F): 2,287 @ $473.19 · Other (J): 1,042 @ $469.40 · Gift (G): 1,042 @ $0 · Option exercise (M): 4,585 (derivative) @ $0EDGAR
2026-11-024Schlosser Michael J — EVP and Chief Clinical OfficerOption exercise (M): 3,030 @ $81.96 · Option exercise (M): 1,898 @ $82.85 · Tax withholding (F): 2,455 @ $478.08 · Option exercise (M): 3,030 (derivative) @ $0 · Option exercise (M): 1,898 (derivative) @ $0 · Grant/award (A): 2,797 (derivative) @ $0EDGAR
2026-08-284McAlevey Michael R — EVP & Chief Legal & Admin Off.Other (J): 7,769 @ $429EDGAR
2026-05-114Marks Mike A — EVP and CFOGift (G): 3,336 @ $0 · Gift (G): 3,336 @ $0EDGAR
2026-04-304Smith Andrea B — DirectorGrant/award (A): 509 @ $0EDGAR
2026-04-304Frist William R — Director, 10% ownerGrant/award (A): 809 @ $0EDGAR
2026-04-304Riley Wayne Joseph — DirectorGrant/award (A): 509 @ $0EDGAR
2026-04-304Johnston Hugh F — DirectorGrant/award (A): 809 @ $0EDGAR
2026-04-304FRIST THOMAS F III — Director, 10% ownerGrant/award (A): 1,041 @ $0EDGAR
2026-04-304MICHELSON MICHAEL W — DirectorGrant/award (A): 925 @ $0EDGAR
2026-04-304DEPARLE NANCY ANN — DirectorGrant/award (A): 509 @ $0EDGAR
2026-04-304CHIDSEY JOHN — DirectorGrant/award (A): 809 @ $0EDGAR
2026-02-184McAlevey Michael R — EVP & Chief Legal & Admin Off.Option exercise (M): 5,000 @ $236.61 · Tax withholding (F): 3,306 @ $540.29 · Sale (S): 1,694 @ $533.37 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-02-124Rossitto Erica — SVP & Chief Nurse ExecutiveGrant/award (A): 1,676 @ $0 · Tax withholding (F): 418 @ $502.05EDGAR
2026-02-124Marks Mike A — EVP and CFOGrant/award (A): 5,026 @ $0 · Tax withholding (F): 1,690 @ $502.05EDGAR
2026-02-124McAlevey Michael R — EVP & Chief Legal & Admin Off.Grant/award (A): 8,372 @ $0 · Tax withholding (F): 3,006 @ $502.05EDGAR
2026-02-124Berres Jennifer — SVP & Chief Human Res. OfficerGrant/award (A): 7,116 @ $0 · Tax withholding (F): 2,515 @ $502.05 · Sale (S): 4,010 @ $503 · Sale (S): 4,010 @ $526.16EDGAR
2026-02-124Wyatt Christopher F. — SVP & ControllerGrant/award (A): 3,350 @ $0 · Tax withholding (F): 1,034 @ $502.05 · Sale (S): 4,000 @ $505EDGAR
2026-02-124Cuffe Michael S. — EVP and Chief Clinical OfficerGrant/award (A): 9,628 @ $0 · Tax withholding (F): 3,501 @ $502.05EDGAR
2026-02-124Foster Jon M — EVP and COOGrant/award (A): 15,696 @ $0 · Tax withholding (F): 5,888 @ $502.05EDGAR
2026-02-124HAZEN SAMUEL N — CEO, DirectorGrant/award (A): 54,934 @ $0 · Tax withholding (F): 21,323 @ $502.05EDGAR
2026-02-104FRIST THOMAS F JR — 10% ownerOther (J): 36,629,188 · Other (J): 36,557,141EDGAR
2026-02-104Frist William R — Director, 10% ownerOther (J): 36,629,188 · Other (J): 36,557,141EDGAR
2026-02-104Elcan Patricia F — 10% ownerOther (J): 36,629,188 · Other (J): 36,557,141EDGAR
2026-02-104Frisco Holding II — 10% ownerOther (J): 36,629,188 · Other (J): 36,557,141EDGAR
2026-02-104HERCULES HOLDING II — 10% ownerOther (J): 36,629,188 @ $0EDGAR
2026-02-104FRIST THOMAS F III — Director, 10% ownerOther (J): 36,629,188 · Other (J): 36,557,141EDGAR
2026-02-094Wyatt Christopher F. — SVP & ControllerOption exercise (M): 10,670 @ $139.06 · Tax withholding (F): 5,674 @ $513.76 · Option exercise (M): 10,670 (derivative) @ $0EDGAR
2026-02-094Foster Jon M — EVP and COOOption exercise (M): 29,330 @ $139.06 · Tax withholding (F): 16,076 @ $513.76 · Option exercise (M): 29,330 (derivative) @ $0EDGAR
2026-02-054Cuffe Michael S. — EVP and Chief Clinical OfficerSale (S): 1,500 @ $498.09 · Gift (G): 4,050 @ $0EDGAR
2026-02-054HAZEN SAMUEL N — CEO, DirectorSale (S): 14,716 @ $502.95 · Sale (S): 5,002 @ $502.15 · Sale (S): 7,395 @ $500.69 · Sale (S): 6,189 @ $500.02 · Sale (S): 5,162 @ $498.80 · Sale (S): 4,293 @ $498.12 · +3 moreEDGAR
2026-02-024Marks Mike A — EVP and CFOGrant/award (A): 11,945 (derivative) @ $0EDGAR
2026-02-024McAlevey Michael R — EVP & Chief Legal & Admin Off.Grant/award (A): 8,067 (derivative) @ $0EDGAR
2026-02-024Berres Jennifer — SVP & Chief Human Res. OfficerGrant/award (A): 6,206 (derivative) @ $0EDGAR
2026-02-024Wyatt Christopher F. — SVP & ControllerGrant/award (A): 2,560 (derivative) @ $0EDGAR
2026-02-024Cuffe Michael S. — EVP and Chief Clinical OfficerGrant/award (A): 8,067 (derivative) @ $0EDGAR
2026-02-024Foster Jon M — EVP and COOGrant/award (A): 11,945 (derivative) @ $0EDGAR
2026-02-024HAZEN SAMUEL N — CEO, DirectorOption exercise (M): 84,360 @ $81.96 · Tax withholding (F): 41,483 @ $488.27 · Grant/award (A): 55,846 (derivative) @ $0 · Option exercise (M): 84,360 (derivative) @ $0EDGAR
2025-11-184HAZEN SAMUEL N — CEO, DirectorGift (G): 14,830 @ $0EDGAR
2025-11-054Marks Mike A — EVP and CFOGift (G): 165 @ $0 · Gift (G): 165 @ $0 · Gift (G): 165 @ $0EDGAR
2025-11-054McAlevey Michael R — EVP & Chief Legal & Admin Off.Option exercise (M): 13,170 @ $236.61 · Tax withholding (F): 9,278 @ $461.56 · Sale (S): 3,892 @ $473.79 · Option exercise (M): 13,170 (derivative) @ $0EDGAR
2025-11-044HAZEN SAMUEL N — CEO, DirectorOption exercise (M): 58,050 @ $69.58 · Tax withholding (F): 28,173 @ $459.68 · Option exercise (M): 58,050 (derivative) @ $0EDGAR
2025-09-084Cuffe Michael S. — EVP and Chief Clinical OfficerOption exercise (M): 10,920 @ $173.12 · Tax withholding (F): 7,084 @ $411.59 · Sale (S): 3,836 @ $418.84 · Option exercise (M): 10,920 (derivative) @ $0EDGAR
2025-07-314CHIDSEY JOHN — DirectorGrant/award (A): 496 @ $0EDGAR

Recent 8-K events — HCA Healthcare, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-028-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-278-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-298-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
EDGAR
2026-07-248-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-148-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-04-308-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-288-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-04-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=HCA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs